HEALTH● LOWAug 26 · Aug 26, 2026, 11:55 AM
Summit rises as lead drug from Akeso outperforms Astra’s Imfinzi in late-stage trial
Seeking Alpha Tech
A drug called Summit, developed by Akeso, has reportedly outperformed Astra's Imfinzi in a late-stage trial. This indicates a significant development in pharmaceutical competition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTHBREAKING8m agoWHO pledges support as Nigeria records first imported Ebola casePremium TimesHEALTH39m agoEbola: Senate Seeks Emergency Funding, Mandatory Screening At All Entry PointsChannels TVHEALTH42m agoWHO supports Nigeria after first Ebola case confirmedUN NewsHEALTH1h agoChristina Applegate Says She Was Misdiagnosed With MSNBC News